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EmbryoA number ofWnt genes are expressed during, and are known to be essential for, early kidney development. It
is typically assumed that their products will act through the canonical β-catenin signalling pathway. We have
found evidence that suggests canonical Wnt signalling is not active in the early nephrogenic metanephric
mesenchyme, but instead provide expressional and functional evidence that implicates the non-canonical
Calcium/NFATWnt signalling pathway in nephrogenesis. Members of the NFAT (Nuclear Factor Activated in T
cells) transcription factor gene family are expressed throughout murine kidney morphogenesis and NFATc3 is
localised to the developing nephrons. Treatment of kidney rudiments with Cyclosporin A (CSA), an inhibitor
of Calcium/NFAT signalling, decreases nephron formation— a phenotype similar to that inWnt4−/− embryos.
Treatment ofWnt4−/− kidneys with Ionomycin, an activator of the pathway, partially rescues the phenotype.
We propose that the non-canonical Calcium/NFAT Wnt signalling pathway plays an important role in early
mammalian renal development and is required for complete MET during nephrogenesis, potentially acting
downstream of Wnt4.Department of Genetics &
1 168th Street, New York, NY
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The mammalian kidney develops as the product of inductive
interactions between the ureteric bud (UB) and the adjacent
metanephric mesenchyme (MM). The UB responds to cues from the
MM to invade it at E10.5 (embryonic day 10.5) and from ~E11.0 the
bud undergoes branching morphogenesis. Concomitant with this
branching the UB signals to the surrounding MM to commence
nephrogenic differentiation. The ﬁrst stage in nephrogenesis is the
condensation of patches of induced MM to form renal aggregates.
These aggregates subsequently undergo a mesenchymal to epithelial
transition (MET), adopting a number of sequential forms: ﬁrstly
epithelised renal vesicles, then comma-shaped bodies and subse-
quently s-shaped bodies, and ﬁnally mature nephrons — the
functional ﬁltration and solute recovery unit of the adult kidney.
Wnt signalling is an essential component of embryonic develop-
ment and is required for a number of important morphogenetic
processes during kidney development (Bridgewater et al., 2008;Carroll et al., 2005; Majumdar et al., 2003; Stark et al., 1994). Correct
development of the embryonic kidney depends on a number of Wnt
genes, including Wnt2b, Wnt4, Wnt9b, and Wnt11 (Merkel et al.,
2007). Wnt4 is expressed in the condensing MM where it is required
for MET. The renal aggregates, vesicles, comma-shaped bodies, s-
shaped bodies, and nephrons which sequentially develop from this
MM also express Wnt4. Mice without functional Wnt4 die shortly
after birth due to renal failure (Stark et al., 1994). Ectopic introduction
of Wnt4 protein into MM cultures can induce nephron formation in
the absence of the UB (Kispert et al., 1998). These ﬁndings showWnt4
is both necessary and sufﬁcient for nephron induction, but which
pathway it acts through is unclear.
In recent years a body of evidence has accumulated to suggest that
the canonical β-catenin Wnt signalling pathway is insufﬁcient for full
nephrogenic MET. The pathway has been shown by a number of
groups to be required for the initiation and maintenance of
nephrogenesis (Kuure et al., 2007; Park et al., 2007; Schmidt-Ott
et al., 2007). However, terminal MET is now thought to require
attenuation of β-catenin signalling and the activity of Wnt4 through a
second, non-canonical pathway (Lyons et al., 2009; Park et al., 2007).
The best characterised non-canonicalWnt signalling pathways are the
planar cell polarity (PCP) and Calcium/NFAT pathways. The PCP
pathway has recently been shown to play a role in renal tubule
morphogenesis, downstream of Wnt9b (Karner et al., 2009). The
Calcium/NFAT pathway is activated upon Wnt-induced increase of
intracellular Ca2+ (Saneyoshi et al., 2002). This rise in Ca2+ levels
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NFAT transcription factors, facilitating their translocation to the
nucleus and subsequent transcriptional activation of target genes.
Five mammalian NFAT transcription factors have been identiﬁed, four
of which are Calcineurin-regulated (NFATc1, NFATc2, NFATc3, and
NFATc4) and one of which is not (NFAT5). Calcineurin/NFAT
signalling regulates a range of cellular processes and plays essential
roles during embryonic development of the heart, skull, and brain
(Arron et al., 2006; Horsley and Pavlath, 2002).
A number of pieces of evidence point to a role for the Calcium/
NFAT pathway in kidney development. Firstly, treatment of rabbit
embryos in utero with Cyclosporin A (CSA), a Calcineurin inhibitor,
reduces nephron number at birth (Tendron et al., 2003). CSA also
inhibits growth of mouse embryonic kidneys in culture, resulting in
decreased proliferation (Alcalay et al., 2007). Treatment of human
proximal tubule cells with CSA results in apoptosis and causes renal
ﬁbrosis due to an epithelial to mesenchymal transition (EMT)
(Slattery et al., 2005). In Xenopus CSA treatment also produces kidney
defects (Yoshida et al., 2004), whilst increasing intracellular Ca2+
promotes pronephric tubule differentiation (Leclerc et al., 2008). In
transgenic mice, loss of the Calcineurin A-α subunit results in a
reduced nephrogenic zone, kidney agenesis, and postnatal lethality
(Gooch et al., 2004). Furthermore, Polycystin-1 − the product of the
PKD1 gene mutated in ~85% of individuals with autosomal dominant
polycystic kidney disease − activates the Calcium/NFAT pathway,
components of which can be detected in late gestation and adult
kidney (Puri et al., 2004). It has also been recently shown that NFATc1
may play roles in UB branching and glomerular development (Yi et al.,
2010), and that conditional activation of NFATc1 in developing
podocytes causes glomerulosclerosis (Wang et al., 2010). Finally,
NFATc4 expression was observed in the embryonic kidney stroma and
interstitium, following detection in a microarray screen of dynami-
cally expressed renal development genes (Challen et al., 2005). On the
basis of these ﬁndings, we investigated the potential role of Calcium/
NFAT signalling during early kidney morphogenesis. We here present
expressional and functional data to support a role for Calcium/NFAT
signalling in nephrogenesis, possibly acting downstream of Wnt4.
Results
The β-catenin Wnt pathway cannot be detected in early nephrogenic
tissue
To study the role of β-catenin in mediating Wnt4 signals in renal
development we examined the canonical Wnt signalling pathway
during early nephrogenesis and found that, whilst highly active in the
UB, it does not appear to be active in early nephrogenic tissues. We
analysed β-catenin reporter activity in three transgenic mouse lines
from E10.5 to 15.5. Reporter activity was absent from the condensing
MM and nascent nephrons in the TOP-gal (data not shown), BAT-gal,
and TCF/Lef:H2B-GFP lines. Strong BAT-gal activity was present in the
UBbut not in the surrounding condensedMMand developing nephrons
whereWnt4 is expressed inwhole (Figs. 1A–C, F), cultured (Fig. 1D), and
sectioned (Fig. 1E) embryonic kidneys. These data support the
hypothesis that an alternative, non-canonical, Wnt pathway may be
active in nephrogenesis. Similarly the TCF/Lef:H2B-GFP transgene is
expressed only in the UB, and not in the condensing MM, during early
nephrogenesis as shown by co-staining with antibodies against
Calbindin, a UB marker (Fig. 1G), and Pax2, a marker of the MM
(Fig. 1H). Furthermore, immunohistochemistry on E11.5 kidneys grown
ex vivo for 48 h failed to detect active (dephosphorylated) β-catenin
protein in the MM or condensing mesenchyme, whilst strong localisa-
tionwas apparent in theUB (Fig. 1I). A pan-β-catenin antibody localised
strongly to the UB but was also in evidence at lower levels in theMM at
E12.5 (Supplementary Fig. 1A) and E18.5 (Supplementary Fig. 1B). The
pan-β-catenin antibody also localised to the maturing nephrogenicstructures at E18.5, reﬂecting the role ofβ-catenin in adherens junctions
of epithelial tissue (Supplementary Fig. 1B). It should be noted that even
in theUB – inwhichβ-catenin signalling is known to be active – this pan
β-catenin antibody was not nuclear localised, illustrating the current
limits on investigating this pathway by immunohistochemistry and
emphasising the importance of reporter models despite their possible
limitations.
Components of the Calcium/NFAT Wnt pathway are present in the
developing kidney
An activated mutant form of β-catenin has been shown to initiate
nephron formation in the MM (Park et al., 2007). However, the
absence of detectable endogenous β-catenin activity from the cap
mesenchyme where Wnt4-induced MET occurs implies it cannot
signal immediately downstream of Wnt4. To investigate the role of
the non-canonical Calcium/NFAT Wnt signalling pathway in kidney
development, we analysed expression of the NFAT transcription
factors in embryonic kidneys using quantitative real-time RT-PCR
(Taqman). All ﬁve NFAT genes were found to be expressed from
E11.5–15.5 (Fig. 2A). The most highly expressed gene was NFAT5,
whose product is not calcium-regulated but loss of which is known to
produce a renal phenotype (Lopez-Rodriguez et al., 2004). Of the
genes encoding calcium-regulated (NFATc) proteins, NFATc4 exhibits
the highest expression during early kidney development (E11.5–
13.5), whilst NFATc3 and NFATc1 dominate at E14.5 and E15.5
respectively. Two distinct RT-PCR expression signatures were iden-
tiﬁed: 1) expression generally increasing from E11.5, peaking at E14.5
and then decreasing – as seen for NFATc1, NFATc2, NFATc3, and NFAT5;
2) expression highest at E11.5 then down regulated as renal
morphogenesis progresses – as with NFATc4. We postulated that
this second pattern may be associated with expression in the
uninduced MM which is abundant at E11.5 then subsequently
undergoes MET and differentiates into nephrons. To address this we
isolated GFP-positive E12.5 MM fromWt1+/GFP embryos (Hosen et al.,
2007) using ﬂuorescence-activated cell sorting (FACS) and repeated
the Taqman analysis on cDNA prepared from this cell population. The
Wt1-GFP knock-in transgene is expressed in the uninduced MM and
subsequently the condensing MM, comma- and s-shaped bodies, and
glomerular podocytes (Fig. 2B). We could therefore compare MM/
MM-derived tissues (Wt1-GFP-positive) against whole kidney, thus
conﬁrming that NFATc4 is the gene most enriched in the MM relative
to the whole kidney (Fig. 2C). The other NFAT genes have higher
relative expression in non-MM tissues at E12.5.
We next performed in situ hybridisation and conﬁrmed renal
expression of NFATc3 (Fig. 2D) and NFATc4 (Fig. 2E) at E13.5. NFATc3
expression was detected in the UB, MM, and epithelial nephrogenic
structures (Supplementary Fig. 2A–B). Expression of NFATc4 was
strongest in the MM (Supplementary Fig. 2C). Data from the GUDMAP
renal expression database (http://www.gudmap.org), supports our
ﬁndings: NFATc3 expression is shown by in situ hybridisation in the
E15.5 UB, MM, tubules, and renal interstitium (AndrewMcMahon lab),
and microarray data reveals NFATc3 expression in the UB, MM, renal
vesicles, s-shaped bodies, and podocytes at E11.5–15.5; microarray
analysis of NFATc4 expression also detected transcripts in the UB, renal
vesicles, podocytes, and proximal tubules at E11.5–15.5, with very high
expression in the E11.5 MM, conﬁrming our RT-PCR data.
A number of antibodies were tested to investigate more precisely
the localisation of the NFAT transcription factors. We could not
identify suitable antibodies against NFATc1 and NFATc4, but obtained
data for NFATc3 and NFATc2. Immunohistochemistry on E12.5
sectioned kidneys (Fig. 3A–C), E14.5 sectioned kidneys (Fig. 3D–F),
and E11.5+72 h cultured kidneys (Fig. 3G–I), revealed strong
localisation of NFATc3 to both the condensing MM and epithelium
(UB, renal vesicles, comma- and s-shaped bodies). This is in
agreement with data in the Human Protein Atlas showing NFATc3
Fig. 1. β-catenin signalling isnot detectable in early nephrogenic tissues, suggesting thatWnt4acts throughanon-canonical pathwayduringnephrogenesis. A-F)X-gal staining in theBAT-
gal reporter mouse conﬁrms β-catenin signalling activity in the UB and absence of detectable activity in the MM and its derivatives, in A–C) ~E11.75–E12.5 whole kidneys (not shown to
scale), D) cultured kidney rudiments (E11.5+72 h), and E) sectioned E13.5 kidneys (counterstained with Nuclear Fast Red). F) Optical Projection Tomography (OPT) analysis of BAT-gal
staining and immunolocalisation ofWt1 in an E12.5 kidney (condensed capMM is denoted bywhite arrows). G–H) Direct ﬂuorescence (green) from the product of the TCF/Lef:H2B-GFP
reporter transgene in cultured (E11.5+18 h) kidneys with antibodies against G) Calbindin (red), a UB marker, and H) Pax2 (red), a marker of the MM. I) Immunohistochemistry on
cultured kidneys (E11.5+48 h) for dephosphorylated (active)β-catenin (green). The signal around the edgeof the cultured tissue is auto-ﬂuorescence.MM—metanephricmesenchyme;
UB — ureteric bud.
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(Berglund et al., 2008)). NFATc2 was nuclear in the MM of E11.5+
72 h cultured kidney rudiments but appeared to be excluded from
more mature aggregates (data not shown).Inhibition of calcium signalling disrupts renal morphogenesis
Given that all the NFAT genes are expressed during renal
morphogenesis and that developmental functional redundancy has
been demonstrated between them in at least two organ systems
(Arron et al., 2006), we decided to manipulate the entire Calcineurin/
NFAT pathway pharmacologically to investigate its role in kidney
development. CSA is an inhibitor of the pathway; when applied to
cultured E11.5 CD1 kidney rudiments the number of UB tips and
nephrons was reduced (Fig. 4A). The same effect was observed using
FK506, a second Calcineurin/NFAT pathway inhibitor (data not
shown), supporting the requirement for Calcineurin/NFAT signalling
during renal development. Removal of CSA from the culture media
rescued these phenotypes, indicating the observed phenotypes were
not due to toxicity. Both drugs target Calcineurin itself and thereforedistinguish between Ca2+ signalling through the NFAT/Calcineurin
pathway and other Ca2+ pathway signals (Liu et al., 1991).
Exogenous activation of calcium signalling disrupts renal morphogenesis
Exogenous activation of the Calcium/NFAT pathway by Ionomycin in
E11.5 cultured kidneysdisrupted renalmorphogenesis. Afterﬁvedays in
culture the UB became bloated (Fig. 5A). The UB branching pattern was
also abnormal (Fig. 5B) and consequently the numbers of UB branches,
tips, and renal aggregates were decreased compared to controls grown
with Dimethyl sulphoxide (DMSO)- or non-supplemented media
(Fig. 5C). The relative reduction was similar for all three parameters
(branches, tips, and aggregates), and approximately the same ratios
were maintained between parameters using all three types of media,
demonstrating that the reduction in nephrogenesis was a result of
decreased branching versus a nephron-speciﬁc effect. The morphology
of the nephrons was normal. DMSO (the solvent for Ionomycin) on its
own exerted a minor positive effect on all three parameters.
These ﬁndings were made using kidneys fromwild type CD1mice;
intriguingly, when the experiments were repeated on the wild type
C57Bl/6 background Ionomycin did not produce such a dramatic
Fig. 2. NFAT genes are expressed during kidney development. A) Quantitative real-time RT-PCR analysis, relative to GAPDH, of E11.5–15.5 whole kidneys reveals that all ﬁve NFAT
genes are expressed. The main graph shows data on the calcium-regulated NFAT genes (NFATc1-c4); the inlay graph also includes data on the non-calcium-regulated NFAT5 gene.
B) Wt1-GFP (green) ﬂuorescence in an embryonic kidney marking the MM and its derivatives. C) Expression analysis of NFATc genes in MM (Wt1-GFP positive) and whole kidney.
Expression of D) NFATc3 and E) NFATc4 was conﬁrmed by in situ hybridisation in E13.5 whole kidneys. G — gonad; K — kidney.
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however maintained the positive effect it had exerted on these para-
meters on the CD1 background, suggesting that speciﬁc buffering may
exist in the C57Bl/6 strain to alterations in the Calcium/NFAT pathway.
This was unexpected but noteworthy: genetic background should be
borne in mind when designing and analysing these types of experiment.
Ectopic activation of calcium signalling partially rescues the Wnt4−/−
kidney phenotype
To further characterise the morphological defects present in CSA,
FK506, and Ionomycin-treated kidney rudiments we next examined thedifferential expression of tissue-speciﬁc markers. E11.5 CD1 kidneys
grown in the presence of each drug were investigated for expression of
markers of the UB (Ret, Wnt11, Ksp-cadherin (Cdh16)), the cap MM
(Six2), proximal tubules (CD15), and podocytes (Synaptopodin) (Fig. 6).
CSA and FK506 showed highly comparable results as would be expected
since both compounds act on Calcineurin. The UB markers were down
regulated following either inhibition or ectopic activation of calcium
signalling, conﬁrmingourearliermorphometric observations. Expression
of the MM-associated genes was also decreased following inhibition —
again, as expected. However, the MM-associated genes were up-
regulated in Ionomycin-treated kidneys, suggesting a pro-nephrogenic
role for calcium signalling. Six2 exhibited the strongest up-regulation.
Fig. 3.NFATc3 is present in the developing nephrons and UB. Immunoperoxidase antibody detection (brown) on sections of A–C) E12.5 and D–F) E14.5 kidneys, and G–I) ﬂuorescent
antibody detection (green) on E11.5+72 h cultured kidney rudiments. In (A–F) cell nuclei are stained blue with haematoxylin; in (G–I) nuclei are DAPI-stained blue. Higher
magniﬁcation images are presented from separate kidneys to increase the range of data shown. CB — comma-shaped body; RV — renal vesicle; SB — s-shaped body; Tu — tubule;
UB — ureteric bud. Black arrows: condensed MM.
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given the decrease in the physical number of renal aggregates
observed in Ionomycin-treated CD1 kidneys (Fig. 5C). However, the
number of UB branches and tips is also greatly reduced in Ionomycin-
treated kidneys; the reduction in aggregate number may simplyFig. 4. Inhibition of calcineurin/NFAT signalling by CSA disrupts renal morphogenesis. A) Cu
(10 μM)media and the numbers of UB tips and nephrons (epithelised bodies within theMM,
renal morphogenesis, when compared to ethanol-treated controls (B, F respectively). The
rescued by removing the CSA-supplemented media at 24 h and replacing it with control me
against Laminin (red; marks basement membrane of epithelia) and Calbindin (green; marktherefore be a consequence of this phenotype as nephron number is
dependent upon UB tip number. Thus the reduction in tip number
could mask any pro-nephrogenic effect. To investigate this further we
employed the Wnt4−/− mouse, in which nephrogenesis is deﬁcient.
The Wnt4 mutant was maintained on the C57Bl/6 background soltured kidney rudiments were grown on control (0.1% ethanol) or CSA-supplemented
at all stages of nephrogenesis) counted. CSA treatment for 24 h (C) or 72 h (G) disrupted
number of both UB tips and nephrons was reduced. D, E) These phenotypes could be
dia for 48 h. (B–G) show immunohistochemistry on cultured kidneys using antibodies
er of UB epithelium).
Fig. 5. Ionomycin disrupts renal morphogenesis in a genetic background-dependent manner. A–B) Control and Ionomycin-treated CD1 kidneys after A) 5 or B) 3 days in culture.
A) Bright ﬁeld, B) immunoﬂuorescence using antibodies against Calbindin (green) and Laminin (red). C) Numbers of branches, tips and aggregates in control and Ionomycin-treated
cultured CD1 kidney rudiments. D) Comparison of branch, tip and aggregate numbers for control and Ionomycin-treated cultured CD1 and C57BL/6 kidney rudiments (data is not
available for C57Bl6 aggregate number in non-supplemented media).
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cussed before (Fig. 5D).
The renal phenotype generated following CSA/FK506 inhibition of
Calcineurin/NFAT signalling is reminiscent of that in the Wnt4−/−
mouse (a reduction in the number of nephrons) and supports the
possibility of NFAT signalling downstream of Wnt4. We therefore
applied Ionomycin to cultured Wnt4−/− kidneys to examine if the
absence of nephrons could be rescued by ectopic activation of the
Calcium/NFAT pathway. Wnt4−/− kidneys cultured on standard or
DMSO-supplemented media failed to undergo MET. By 72 h in culture
they have no or very few renal aggregates, none of which progress
beyond the comma-shaped stage (Figs. 7A, D). This phenotype was
rescued when the kidneys were cultured on Ionomycin-supplemen-
ted media (Fig. 7B). The number of renal aggregates was signiﬁcantly
increased by Ionomycin (p=0.047 using a two sample t-test
assuming unequal variance). This effect is speciﬁc to nephrogenesis;
the numbers of UB branches and tips were not increased by
Ionomycin. All treated mutant rudiments developed aggregates, and
both comma- and s-shaped bodies were observed (Fig. 7H). Mostimportantly, a distinct shift towards more mature renal MET-derived
structures occurred: not only did the overall number of epithelised
structures increase, but the proportion of these reaching the s-shaped
state returned to that observed in wild type/heterozygous littermates
(Fig. 7I). The total number of aggregates was still lower in the
Ionomycin-rescuedWnt4−/− kidneys but this is expected asWnt4−/−
kidneys are smaller than those of wild type/heterozygous littermates
at E11.5. The effect on number of s-shaped bodies is statistically
signiﬁcant (p=0.033), suggesting that Ionomycin can push renal
aggregates further through MET. Ectopic activation of the Calcium/
NFAT pathway therefore rescues the nephrogenic defect in Wnt4−/−
kidneys, and demonstrates the sufﬁciency of the pathway to
overcome the block in MET caused by absence of Wnt4.
Discussion
Nephrogenesis is the process by which nephrons, the functional
units of the adult kidney, are generated. It comprises a highly
orchestrated series of events and intermediate forms, controlled by
Fig. 6. Disruption of calcium signalling reduces expression of UB genes but ectopic activation promotes nephrogenic gene expression. Quantitative real-time RT-PCR on E11.5 CD1
kidneys cultured for 72 h in the presence of CSA, FK506 or Ionomycin normalised to the relevant solvent-only control. CSA: 10 μM in ethanol; FK506: 10 μM in ethanol; Ionomycin:
1 μM in DMSO; ethanol: 0.1%; DMSO: 0.1%.
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that the adult human kidney contains ~500,000–1,000,000 nephrons,
and the mouse kidney ~12,000 (Vainio and Lin, 2002). Low nephron
number at birth is a known risk factor for renal and hypertensive
problems later in life (Hoy et al., 2005). Complete failure to produce
nephrons results in renal agenesis and postnatal death due to renal
failure — as seen in mice with homozygous loss of Wnt4 (Stark et al.,
1994).
Wnt4 is expressed in the condensing MM of the kidney from E11.5.
Expression is then maintained in each of the intermediate epithelised
structures which sequentially develop from the condensed MM
during nephrogenesis: the aggregates, renal vesicles, comma- and s-
shaped bodies. Down regulation occurs once the mature epithelial
tubules fuse with the UB-derived collecting duct system (Stark et al.,
1994). Wnt4 induces nephrogenic MET: exogenous Wnt4 is sufﬁcient
to induce MET in isolated MM (Kispert et al., 1998), whilst Wnt4−/−
mouse embryos harbour a defect in MET of the MM. Wnt4−/− MM
condenses normally but then fails to undergo complete MET, instead
forming a greatly reduced number of simple renal aggregates (Stark
et al., 1994). Poorly developed comma-shaped or more mature bodies
may also sometimes be observed, however these are extremely rare
(personal observation; (Kobayashi et al., 2005; Perantoni et al.,
2005)). Wnt4−/− mice are thus born without nephrons and con-
sequently die of renal failure.
In this paper we have shown that components of the non-
canonical Calcium/NFAT Wnt signalling pathway are present in the
mid-gestation embryonic kidney. This supports previous data that a
pan-NFAT antibody localises to the renal vesicles, s-shaped bodies,
tubules, and UB tips at late gestation, as well as to adult tubules and a
cortical collecting duct cell line (in which expression of the NFAT
genes can also be detected) (Puri et al., 2004). Pharmacological
suppression of the Calcineurin/NFAT pathway stunted kidney devel-
opment and reduced nephron number - a phenotype similar to that in
Wnt4−/− mutants. Moreover, we demonstrate that activation of
calcium signalling rescues the defect in nephrogenesis in Wnt4−/−
cultured kidneys. Not only was the overall number of epithelisedstructures increased in Ionomycin-treated mutant kidneys, but a
signiﬁcant shift towards more mature nephrogenic states was also
noted. The number of comma- and s-shaped bodies increased — the
latter structure never being observed in untreated mutant kidneys in
our studies. Activation of calcium signalling by Ionomycin is therefore
sufﬁcient to pushWnt4−/− kidneys through the block in MET. Due to
limitations of the kidney culture system it is not possible to see
whether these s-shaped bodies proceed to form fully differentiated
functional nephrons; however, the rescued s-shaped bodies were
morphologically comparable to those in wild type cultured kidneys,
albeit smaller. The ratio of branches to aggregates however remained
higher in Ionomycin-treated mutant kidneys compared with wild
type kidneys, indicating that the rescue is not complete.
Previous studies of Wnt signalling in early kidney development
have focused largely on the canonical β-catenin signalling pathway. In
the β-catenin pathway, Wnt proteins bind to membrane-bound
Frizzled receptors, activating a Dishevelled-containing complex
which exerts an inhibitory effect on a second complex containing
GSK3β. Once inhibited GSK3β can no longer target β-catenin for
degradation and thus the stabilised β-catenin protein can translocate
to the nucleus where it co-operates with a host of other factors to
transactivate gene expression. The UB branches under the control of
the canonical β-catenin pathway (Bridgewater et al., 2008). A number
of pieces of evidence have also pointed to a pro-nephrogenic role for
the canonical pathway in the MM. Removal of β-catenin activity
speciﬁcally in the nephron progenitor MM inhibits renal vesicle
formation (Park et al., 2007). Isolated MM cannot undergo nephro-
genesis as it does not receive UB-derived inductive signals; however
pharmacological activation of β-catenin signalling in isolated MM
using GSK3β inhibitors partially rescues this phenotype as treated
MMs initiate MET and tubulogenesis (Davies and Garrod, 1995). The
induced epithelised structures do not however undergo terminalMET.
In cultured kidney cells, competent to form tubules, stabilisedβ-catenin
promotes cell growth and survival, but not tubulogenesis (Lyons et al.,
2004). Similarly, adenoviral transfer of constitutively active β-catenin
into isolated MM promotes cell-autonomous survival of epithelial
Fig. 7. Ectopic activation of Calcium/NFAT signalling partially rescues theWnt4−/− phenotype. A) Nephrogenesis is disturbed inWnt4−/− kidneys, as demonstrated by the absence of
Laminin (red) marked aggregates in an E11.5 kidney grown in non-supplemented media for 72 h (green: Calbindin). B) The total number of renal aggregates (aggregates, renal
vesicles, comma shaped bodies, s-shaped bodies) in wild type, Wnt4+/− and Wnt4−/− E11.5 kidney rudiments after 72 h culture in control or Ionomycin-supplemented medium.
C) Number of UB branches and tips in control and Ionomycin-treated cultures. D–G) Immunoﬂuorescense of control (D) or Ionomycin-treated (E–G) Wnt4-deﬁcient kidney
rudiments from the same embryo using Laminin (red, epithelialised nephrons) and Calbindin (green, UB) antibodies. H) Enlarged examples of the different stages of nephron
formation found in Ionomycin-treated kidneys (not to scale). I) Quantiﬁcation of different stages of renal aggregates.
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terminalMET (Schmidt-Ott et al., 2007).MM-speciﬁc genetic activation
ofβ-catenin in culturedMMalso initiates tubulogenesis, but again is not
sufﬁcient for the formation of mature epithelial structures (Park et al.,
2007). In vivo this genetic activation can functionally replaceWnt9b and
Wnt4 in the induction of nephrons — but once more is insufﬁcient for
full nephrogenic MET (Park et al., 2007).
The emergent hypothesis from these studies is that nephrogenesis
may be biphasic: canonicalWnt signalling initiatesMET butmust then
be attenuated and a second, non-canonical Wnt pathway initiated for
terminal MET. In this paper we report a lack of detectable β-catenin
pathway activity and the presence of components of the Calcium/
NFAT pathway in the nephrogenic MM and resultant epithelised
structures. Furthermore, we show that inhibition of the Calcineurin/
NFAT pathway in cultured kidney rudiments disrupts renal morpho-
genesis and that exogenous activation of the pathway rescues the
nephrogenic deﬁcit in Wnt4−/− kidneys. These ﬁndings support the
idea that a non-canonical Wnt pathway is required for a full MET.
Can our ﬁndings be reconciled with those on the canonical
pathway? It is certainly conceivable that nephrogenesis involves a
number of Wnt signalling pathways, each with distinct roles at
different stages, and with crosstalk between them. A biphasicprogram of Wnt-mediated nephrogenesis would be one possible
way to marry our data with previous ﬁndings. In the ﬁrst phase, from
E11.5, low level activation of the β-catenin pathway in the MMwould
induce Wnt4 and the initiation of nephrogenesis. Once β-catenin
signalling has fulﬁlled its role in this initial induction it would need to
be attenuated in order for complete MET to occur. Intriguingly, Wnt4
has been previously shown to inhibit canonical Wnt signalling (in
HEK-293 T cells) (Bernard et al., 2008). Following attenuation, a
second phase would now occur in which β-catenin signalling is down
regulated and a second Wnt pathway takes over. Our data would
support the role of the Calcium/NFAT pathway in this latter phase.
This biphasic model ﬁts with previous ﬁndings: 1) that activation
of β-catenin signalling is sufﬁcient to induce nephrogenesis in isolated
MM; 2) that isolatedMM inwhich β-catenin is activated andWnt4−/−
kidneys cannot progress beyond the comma-shaped body stage, and
stabilisation of β-catenin seems to be inhibitory on MET in wild type
kidneys at this stage. The model also supports the data presented
here: 1) that NFAT genes are expressed in the developing kidney, with
NFATc1, NFATc2, and NFATc3 expression increasing as MET progresses,
and NFATc3 localising to the developing nephrons; 2) that exogenous
Calcium/NFAT signalling supports terminalMET in the form of s-shaped
and more mature epithelial bodies inWnt4−/− kidneys.
296 S.F. Burn et al. / Developmental Biology 352 (2011) 288–298A major drawback to the foregoing model is that in our studies we
simply do not see activation of the β-catenin pathway during early
nephrogenesis. Similarly, Wnt4 fails to activate the canonical TOPFLASH
reporter in nephrogenic MM cells (Iglesias et al., 2007). In an
accompanying paper Tanigawa et al., 2011 also describe that the
canonical pathway is inactive in theMM. Itmust therefore be considered
a possibility that the canonical β-catenin pathway does not endoge-
nously induce nephrogenicMET and that the ability of pharmacologically
stabilised β-catenin to induce MET may reﬂect its role in epithelial
adherens junctions. It should also be noted that the GSK3β inhibitors
used in the experiments outlined earlier are not speciﬁc to the canonical
pathway. GSK3β inhibitors also prevent re-phosphorylation (and
therefore nuclear export) of NFAT proteins and enhance NFATc DNA
binding activity, thus facilitating activation of the Calcium/NFATpathway
(Beals et al., 1997; Neal and Clipstone, 2001). Tanigawa et al., 2011 have
now generated a peptide which speciﬁcally targets canonical Wnt
signalling. Using this peptide they were able to show that disruption of
canonicalWnt signalling does not disrupt tubule formation. Furthermore
they demonstrate that Wnt4 induces Ca2+ inﬂux, CaMKII phosphoryla-
tion, and activation of an NFAT reporter construct in MM cells, and
that Ionomycin promotes nephrogenesis in isolated MM. This pro-
nephrogenic effect complements our ﬁnding that nephrogenic genes are
up-regulated in Ionomycin-treated kidneys, particularly Six2. Nephro-
genesismay therefore initiate solely due to non-canonicalWnt signalling
in vivo. The fact that theoverall numberof renal aggregates in Ionomycin-
treated Wnt4−/− kidneys increased would support this model. We also
occasionally noted aggregates forming ectopically (away fromUB tips) in
the MM of wild type kidneys treated with Ionomycin (Fig. 5B), again
supporting a pro-nephrogenic effect of calcium signalling.
Alternatively, a biphasic system could still exist if the UB were the
source of the canonical Wnt signal. It is plausible that canonical
signalling fromtheUB, possibly activatedbyWnt9b(Carroll et al., 2005),
inducesWnt4 expression in theMMand that the canonical pathway can
act similarly when ectopically activated in the MM. A ﬁnal possibility is
that canonical β-catenin signalling has a role in nephrogenesis at stages
later than those onwhichwe have focused. Indeed,Mugford et al., 2009
detected activation of an Axin2-LacZ knock-in construct in the kidney at
E15.5 but not E11.5.We did not see this activity in our BAT-galmice but
differences in activity between transgenes reporting on different
components of a pathway are to be expected.
A ﬁnal issue to address is the lack of kidney abnormalities in NFATc
gene mutants. Mice homozygous for loss of NFAT5 display renal atrophy
(Lopez-Rodriguezet al., 2004), but theproduct of this gene isnot calcium-
regulated. Of the knockout models generated for the four NFATc genes,
nonedisplayobvious renaldefects (personal communications).However,
themajor cardiac andbrain developmental defects associatedwith loss of
these genes only become apparent in double and triple knockout mice,
indicating that functional redundancy exists between NFATc gene family
members (Arron et al., 2006). It is therefore interesting to note that
homozygous loss of the gene encoding the Calcineurin A-α catalytic
subunit (Ppp3ca) results in a reduced nephrogenic zone and renal
agenesis (Gooch et al., 2004). Moreover, Ppp3ca is strongly expressed in
the capMMwherenephrogenesis occurs andWnt4 is expressed (Andrew
McMahon lab data, deposited in the renal expression database at http://
www.gudmap.org). As Calcineurin regulates all four of the NFATc
transcription factors its loss would therefore abrogate all downstream
NFATc activity and bypass redundancy between the NFAT proteins. We
therefore propose the non-canonical Wnt Calcium/NFAT pathway as a
novel regulator of nephrogenesis.
Materials and methods
Kidney organ culture
T-bud stage kidneys were isolated from E11.5 mouse embryos and
cultured at 37 °C with 5% CO2 on 0.4 μm pore Transwell ﬁlters (Costar3450) suspended on Minimum Essential Medium Eagle medium
(Sigma M5650) supplemented with 10% foetal calf serum and 1%
Penicillin/Streptomycin. CSA, FK506, Ionomycin, ethanol, and DMSO
were added to the media underlying the ﬁlter where required at the
concentrations stated in the text/ﬁgures.
Immunohistochemistry, X-gal staining, and in situ hybridisation
Immunohistochemistry was performed on cultured or microtome-
sectioned kidneys. Cultured kidneys were ﬁxed in ice-cold methanol
for 10 min, washed in phosphate buffered saline (PBS), blocked
overnight in PBS/2% BSA/0.01% sodium azide at 4 °C, incubated
overnight at 4 °C with primary antibodies in PBS/BSA/azide, washed
in PBST (1% Triton), incubated overnight with secondary antibodies in
PBS/BSA/azide at 4 °C, washed in PBST, and mounted in Vectashield
(Vectorlabs).
For section immunohistochemistry, whole embryonic kidneys were
ﬁxed in 4% paraformaldehyde (PFA), washed in PBS, dehydrated
through an ethanol series, cleared using Histoclear (National Diagnos-
tics), embedded in parafﬁn wax, and sectioned using a microtome.
Sectionsweredewaxed inXylene,washed in ethanol and, if theywere to
undergo immunoperoxidase antibody detection, blocked for endoge-
nous peroxidase activity with 0.3% hydrogen peroxide. Following
dehydration in 70% ethanol, sections were washed in water, subjected
to microwave antigen retrieval in Tris/EGTA buffer, washed in 50 mM
ammonium chloride, washed in PBS containing 0.2% gelatin/1% BSA/
0.05% Saponin, and incubatedwithprimary antibodies at 4 °C overnight.
The next day sections were washed in 0.2% gelatin/0.1% BSA/0.05%
Saponin in PBS prior to incubation with secondary antibodies at room
temperature. Incubation with peroxidase-conjugated secondary anti-
bodies was followed bywashes in 0.2% gelatin/0.1% BSA/0.05% Saponin,
DAB treatment, PBS and water washes, counterstaining with Haema-
toxylin, dehydration, clearing in Xylene, then mounting in DePeX.
Sections incubated with ﬂuorescent secondary antibodieswere washed
in PBS and water then mounted using Vectashield.
Primary antibodies used were as follows: anti-calbindin (D28K,
clone CL-300, ab9481, Abcam; D28K, clone C-20, sc-7691, Santa Cruz),
anti-Pax2 (71–6000, Invitrogen), anti-dephosphorylated β-catenin
(clone 8E4, C-1202, AG Scientiﬁc), anti-pan β-catenin (C2206, Sigma;
95825, Cell Signaling Technology) , anti-NFATc3 (F-1, sc-8405, Santa
Cruz), and anti-laminin (L9393, Sigma).
Whole kidneys were ﬁxed with 4% PFA/PBS prior to overnight X-
gal staining at 37 °C. Stained ﬁxed kidneys were embedded and
sectioned as before, and sections counterstained with Nuclear Fast
Red (Vector Laboratories). Cultured kidneys were ﬁxed in 4% PFA/PBS
then X-gal stained overnight at 37 °C and re-ﬁxed.
NFATc3 and NFATc4 expression was analysed by in situ hybridisa-
tion, using DIG-labelled antisense RNA probes reverse transcribed
from a PCR product template (NFATc3 F: CCTTTGAGTGCCCAAGTATTC,
R: CGATGTTAATACGACTCACTATAGGGCTGAGGCCTGATCCAGTGTGG;
NFATc4 F: ATAGCTGGCTACTCCTCAGC, R: CGATGTTAATACGACTCAC-
TATAGGGCACCATCTTGCCAGTAATCCG). In situ hybridisation was
performed essentially as described by Wilkinson (1992). Detection
was performed with BM Purple (Roche Applied Science).
Mice
All animal experiments were approved by the University of
Edinburgh ethical committee (UK) or conducted under PHS guidelines
and approved by the relevant Institutional Animal Care and Use
Committees (USA). Experiments were conducted on CD1 wild type
mice, unless otherwise stated. BAT-gal, Wt1-GFP, and TOPgal
transgenic mice have been previously described (DasGupta and
Fuchs, 1999; Hosen et al., 2007; Maretto et al., 2003). The TCF/Lef:
H2B-GFP transgene comprises six copies of a Lef/TCF binding site,
upstream of an Hsp68 minimal promoter and an H2B-GFP fusion
297S.F. Burn et al. / Developmental Biology 352 (2011) 288–298reporter. A detailed characterisation of the TCF/Lef:H2B-GFP Wnt
reporter line will be provided elsewhere (Ferrer-Vaquer et al., 2010).
Embryonic day 0.5 (E0.5) was the morning when a vaginal plug was
detected.
Real-time quantitative RT-PCR
RNA was isolated from whole wild type E11.5–15.5 embryonic
kidneysusing anRNeasyMini kit (QIAGEN). For RNA isolation after drug
treatment kidney rudiments were stored in RNAlater (Ambion),
subsequently lysed in RLT buffer with β-mercapto-ethanol on the ﬁlter,
and further treated as per manufacturer's instructions using the same
kit. Control sampleswere treatedwith solvent only (EtOH for FK506 and
CSA; DMSO for Ionomycin). GFP-positive cells were isolated from E12.5
Wt1-GFP transgenic kidneys using a FACSaria II cell sorter (BD) and RNA
isolated from GFP-sorted cells with an RNeasy Micro kit (QIAGEN).
cDNAwas subsequently synthesisedusing a First Strand cDNASynthesis
Kit (Roche). Taqman RT-PCR using the Universal Probe Library (Roche)
was performed according to themanufacturer's instructions as follows:
NFATc1 (NFAT2) — F: tccaaagtcattttcgtgga, R: tttgcttccatctcccagac, probe
50; NFATc2 (NFAT1) — F: gatcgtaggcaacaccaagg, R: cttcaggatgcctgcaca,
probe 1; NFATc3 (NFAT4) — F: caagatggaagacctcattgg, R:gggaggaactt-
caaggacaa, probe 41; NFATc4 (NFAT3) — F: cggcttcagagacagtgtacc,
R: gtctcggccaatgatctcac, probe 69; NFAT5 — F: gacaccttcttcccccattt, R:
gcttttctttaagatctcaggaactc, probe 102; Ret — F: tggagtttaagcggaaggag, R:
acatctgcatcgaacacctg, probe 49; Wnt11 — F: gagctcgcccccaactac, R:
ggcatacacgaaggctgact, probe 85; Ksp-cadherin — F: ggttgtccaccatgataccc,
R: tgcagcgacacacaatcac, probe 85; Six2 — F: caagtcagcaactggttcaaga, R:
actgccattgagcgagga, probe 5; CD15 — F: tggtactacgcgtgttcgac, R:
ccagggctttgccagtta, probe 32; Synaptopodin — F: ggaaagtgatgacagccagtg,
R: ttttcggtgaagcttgtgct, probe 104. All assays used a commercially
available UPL compatible Gapdh assay (Roche) as internal control. All
assays except for CD15 (which is encoded by the single exon Fut4 gene)
were intron-spanning.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.033.
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